Zhejiang Benli Technology Co., Ltd. (SHE:301065)

Market Cap	2.34B
Revenue (ttm)	682.58M
Net Income (ttm)	63.23M
Shares Out	103.17M
EPS (ttm)	0.61
PE Ratio	37.11
Forward PE	n/a
Dividend	0.20 (0.87%)
Ex-Dividend Date	Jun 20, 2024

Volume	6,560,494
Average Volume	4,429,229
Open	22.16
Previous Close	22.95
Day's Range	22.16 - 23.77
52-Week Range	14.93 - 25.26
Beta	0.17
RSI	56.39
Earnings Date	Apr 24, 2025

About Zhejiang Benli Technology

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sale of pharmaceutical, pesticide, and other material intermediates in China and internationally. Its products include N,N-Dimethylamino ethyl acrylate; 2,4-Dichloro-5-fluorobenzoyl chloride; 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamino acrylate ethyl ester; 1-Ethyl-7-(1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride; 2,4-Dichlorofluorobenzene; Methyl 3-Methoxyacrylate; Ethyl 3-ethoxyacrylate; 2,6-Dichlorofluorobenz...

• Industry: Chemicals
• Sector: Materials
• Founded: 2011
• Employees: 589
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301065

Financial Performance

In 2024, Zhejiang Benli Technology's revenue was 708.83 million, an increase of 1.57% compared to the previous year's 697.89 million. Earnings were 64.57 million, an increase of 8.31%.